Stericycle, Inc. (NASDAQ:SRCL) had its price objective decreased by Royal Bank Of Canada from $74.00 to $67.00 in a research report sent to investors on Thursday, Marketbeat.com reports. Royal Bank Of Canada currently has an underperform rating on the business services provider’s stock.

Several other equities research analysts also recently issued reports on SRCL. Jefferies Group LLC restated a buy rating and set a $108.00 price objective on shares of Stericycle in a research report on Thursday, July 13th. BidaskClub upgraded shares of Stericycle from a strong sell rating to a sell rating in a research report on Monday, July 24th. Zacks Investment Research downgraded shares of Stericycle from a buy rating to a hold rating in a research report on Monday, August 7th. Barclays PLC restated an overweight rating and set a $100.00 price objective on shares of Stericycle in a research report on Wednesday, August 9th. Finally, William Blair restated an ourperform rating on shares of Stericycle in a research report on Thursday, September 14th. Four investment analysts have rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating to the company’s stock. Stericycle presently has an average rating of Hold and an average price target of $77.17.

Shares of Stericycle (NASDAQ SRCL) traded down $0.04 during trading hours on Thursday, reaching $64.02. 1,738,000 shares of the company traded hands, compared to its average volume of 818,549. Stericycle has a twelve month low of $61.62 and a twelve month high of $88.00. The firm has a market cap of $5,470.00, a P/E ratio of 14.75, a P/E/G ratio of 1.75 and a beta of 0.19. The company has a debt-to-equity ratio of 0.93, a current ratio of 0.82 and a quick ratio of 0.82.

Stericycle (NASDAQ:SRCL) last issued its quarterly earnings data on Wednesday, November 8th. The business services provider reported $1.10 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.14 by ($0.04). The company had revenue of $883.00 million for the quarter, compared to analyst estimates of $896.81 million. Stericycle had a positive return on equity of 13.93% and a negative net margin of 0.79%. The company’s revenue was down .8% on a year-over-year basis. During the same quarter last year, the business earned $1.24 earnings per share. equities research analysts anticipate that Stericycle will post 4.49 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “Stericycle, Inc. (SRCL) Price Target Cut to $67.00 by Analysts at Royal Bank Of Canada” was first posted by Watch List News and is owned by of Watch List News. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.watchlistnews.com/stericycle-inc-srcl-price-target-cut-to-67-00-by-analysts-at-royal-bank-of-canada/1700948.html.

In other news, Director Mark C. Miller sold 19,753 shares of the firm’s stock in a transaction that occurred on Monday, October 30th. The shares were sold at an average price of $70.52, for a total transaction of $1,392,981.56. Following the transaction, the director now directly owns 205,576 shares of the company’s stock, valued at $14,497,219.52. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 3.30% of the stock is currently owned by company insiders.

Large investors have recently made changes to their positions in the stock. Pacer Advisors Inc. increased its stake in Stericycle by 8.4% in the second quarter. Pacer Advisors Inc. now owns 1,880 shares of the business services provider’s stock valued at $143,000 after acquiring an additional 145 shares during the last quarter. NEXT Financial Group Inc increased its stake in Stericycle by 77.9% in the third quarter. NEXT Financial Group Inc now owns 2,322 shares of the business services provider’s stock valued at $164,000 after acquiring an additional 1,017 shares during the last quarter. Benjamin F. Edwards & Company Inc. increased its stake in Stericycle by 8.5% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 2,540 shares of the business services provider’s stock valued at $194,000 after acquiring an additional 200 shares during the last quarter. Cadence Capital Management LLC bought a new position in Stericycle in the third quarter valued at approximately $234,000. Finally, Intact Investment Management Inc. bought a new position in Stericycle in the second quarter valued at approximately $237,000. 94.19% of the stock is currently owned by institutional investors and hedge funds.

About Stericycle

Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.

Analyst Recommendations for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.